FDA official who scrutinized COVID shots and antidepressants is out in latest shake-up
Summary
Dr. Tracy Beth Hoeg, an official at the U.S. Food and Drug Administration (FDA), has been removed from her role leading the agency’s drug program. Her departure comes amid a series of leadership changes at the FDA, including the recent resignation of the FDA Commissioner Marty Makary.Key Facts
- Dr. Tracy Beth Hoeg was removed from her position as acting director of the FDA’s drug center.
- Dr. Mike Davis, the deputy director, will replace Hoeg as acting director.
- FDA Commissioner Marty Makary resigned earlier in the same week.
- Another recent resignation was Dr. Vinay Prasad, who led the FDA’s vaccine and biotech center.
- Karim Mikhail was named acting director of the FDA’s vaccines center.
- Hoeg was promoted rapidly by Makary despite having no prior government or management experience.
- She has led investigations into the safety of antidepressants, COVID-19 vaccines, and other drugs since joining the FDA in March.
- Hoeg has expressed controversial views on vaccines and public health measures and was involved in efforts to drop some federal childhood vaccine recommendations.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.